Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRP-8802 and Psychotherapy for Binge Eating Disorder
NCT05035927Phase 2Completed
- Sponsor
- Tryp Therapeutics
- Start
- Mar 2022
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in binge eating disorder (BED), sponsored by Tryp Therapeutics. Started Mar 2022; status: completed.
02
Drugs
psilocybin
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on NCT05035927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05035927.